Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- National Institutes of Health (2)
- Patent applications (2)
- Patent law (2)
- Public domain (2)
- Public policy (2)
-
- Research and development (2)
- Technology transfers (2)
- Bayh-Dole Act (1)
- Corporations (1)
- DNA sequences (1)
- Decision-making (1)
- Decisions (1)
- Exclusivity (1)
- Experts (1)
- Federal agencies (1)
- Funding (1)
- Human Genome Project (1)
- Incentives (1)
- Opinion (1)
- Patent system (1)
- Risk (1)
- Scientific research (1)
- Sponsored research (1)
- Statistics (1)
- Publication
Articles 1 - 3 of 3
Full-Text Articles in Law
Roundtable Discussion: Science, Environment, And The Law, James E. Krier
Roundtable Discussion: Science, Environment, And The Law, James E. Krier
Articles
Science, environment, and the law is our topic. The problem of interest to me has to do with risk regulation and, more particularly, with the fact that technical and scientific views of risk differ dramatically from lay or public views. How is this conflict to be managed and resolved? I have to go through my account very quickly, given the time constraint, so let me mention that it is based on an article that sets out my arguments at length.'
Limiting The Role Of Patents In Technology Transfer, Rebecca S. Eisenberg
Limiting The Role Of Patents In Technology Transfer, Rebecca S. Eisenberg
Other Publications
Federal policy since 1980 has reflected an increasingly confident presumption that patenting discoveries made in the course of government-sponsored research is the most effective way to promote technology transfer and commercial development of those discoveries in the private sector. Policymakers in the past may have thought that the best way to achieve widespread use of government-sponsored research was to make the results freely available to the public; the new pro-patent policy stresses the need for exclusive rights as an incentive for industry to invest in bringing new products to market.
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
A Technology Policy Perspective On The Nih Gene Patenting Controversy, Rebecca S. Eisenberg
Articles
This article will use the NIH patent controversy as a focal point for considering when the results of government-sponsored research should be patented and when they should be dedicated to the public domain. First, this article will review the recent history of federal government policy on patenting the results of government-sponsored research. Next, this article will highlight some of the complexities involved in achieving technology transfer from the public sector to the private sector that current policy may oversimplify. With this background, this article will return to a more detailed analysis of the NIH cDNA patenting controversy and consider the …